Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
ACDN-01 by Ascidian Therapeutics for Juvenile Macular Degeneration (Stargardt Disease): Likelihood of Approval
ACDN-01 is under clinical development by Ascidian Therapeutics and currently in Phase II for Juvenile Macular Degeneration (Stargardt Disease). According...
Data Insights
ACDN-01 by Ascidian Therapeutics for Retinopathy: Likelihood of Approval
ACDN-01 is under clinical development by Ascidian Therapeutics and currently in Phase II for Retinopathy. According to GlobalData, Phase II...